ScienceFi · drug repurposing · Solana
DeCure searches approved medicines for new uses, folds the strongest candidates and publishes the evidence. DeGame turns that research map into a playable world across 12 labs and 5,000 diseases.
The molecule already exists, but the new use may be too small, too early or too hard to finance. Second-use protection is often narrow, and the patient group may be small. Good research questions stall there.
AI maps the disease, structured evidence ranks approved medicines, our AI folds the strongest pairs and a real lab tests what survives. Methods and raw data are published either way.
Methods, raw data and analysis are released as an open research package that anyone can inspect, reproduce or continue.
One public token: your vote on which lab and which disease DeCure researches. Stakers share up to half of every trading fee in SOL, claimed in DeGame: take the SOL, or buy back & burn $DECURE and keep your vote streak.
Stake $DECURE and point your position at one of the twelve labs. The longer your tokens stay, the more weight they carry.
In the demo, points are free and nothing is on-chain. In the live game, playing earns more voting weight. The board shows which labs are attracting attention.
Staking directs how the research budget is split across the twelve labs. Every lab keeps at least 5% and no lab can take more than 40%.
There is one public token. Weight comes from how long you lock it, not from collecting extra coins.
Each completed campaign adds an evidence package to the public record — including the negative results, which count too.
A computational result earns attention. Only experimental evidence earns confidence.
The game is the front door. The disease pages are the evidence.
Disease pages are research, not medical advice, and no claim is made that a treatment exists. $DECURE is volatile and may lose all value; it confers no ownership of any paper, patent or laboratory. Demo points have no monetary value. See all 5,000 DeCures →.